Search
Menu

Detecting early-stage Lyme

Facebook X LinkedIn Email
DOUGLAS FARMER, SENIOR EDITOR [email protected]

Lyme disease continues to infect a large swath of the population in North America. The reliance on the standard two-tiered serodiagnostic test to identify its presence has proved problematic because the bacteria that cause the disease — Borrelia burgdorferi — can be difficult to trace in the early stages. Some in the biomedical community are pinning their hopes for reliable testing on the photonics technologies found in chip-based assays and used to measure effects such as fluorescence and absorption. The Tick-Borne Disease Working Group has placed this pursuit of reliable...Read full article

Related content from Photonics Media



    Articles


    Webinars
    Published: May 2021
    Editorial

    We use cookies to improve user experience and analyze our website traffic as stated in our Privacy Policy. By using this website, you agree to the use of cookies unless you have disabled them.